SCHEMBL15828541

SCHEMBL15828541

CCOC(=O)c1cn([C@@H]2C[C@@H]2F)c2c(C)c(I)c(F)cc2c1=O

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.47
STAT3 P40763 2/20 0.45
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 3/20 0.41
HPGD P15428 3/20 0.41
ALDH1A1 P00352 2/20 0.41
HSD17B10 Q99714 2/20 0.41
KCNH2 Q12809 2/20 0.39
HTT P42858 1/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
CYP3A4 P08684 1/20 0.38
LMNA P02545 1/20 0.37
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15828542 0.91 ADRB2 (0.45) ADRB2STAT3KMT2AKDM4EHPGD
SCHEMBL13483643 0.90 STAT3 (0.51) ADRB2STAT3KMT2AKDM4EHPGD
SCHEMBL7511615 0.90 STAT3 (0.51) ADRB2STAT3KMT2AKDM4EHPGD
SCHEMBL7511613 0.90 STAT3 (0.51) ADRB2STAT3KMT2AKDM4EHPGD
SCHEMBL2670291 0.88 ADRB2 (0.47) ADRB2STAT3KMT2AKDM4EHPGD
SCHEMBL15828543 0.88 ADRB2 (0.59) ADRB2STAT3KMT2AKDM4EHPGD
SCHEMBL10365215 0.87 STAT3 (0.55) ADRB2STAT3KMT2AKDM4EHPGD
SCHEMBL21729419 0.87 ADRB2 (0.46) ADRB2STAT3KMT2AKDM4EHPGD
SCHEMBL9096923 0.85 STAT3 (0.48) ADRB2STAT3KMT2AKDM4EHPGD
SCHEMBL9097649 0.85 STAT3 (0.48) ADRB2STAT3KMT2AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210032207-A1 QUINOLONE COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2021-02-04 US disclosed
US-20200055823-A1 QUINOLONE COMPOUND OTSUKA PHARMA CO LTD (JP) 2020-02-20 US disclosed
US-20190077762-A1 QUINOLONE COMPOUND OTSUKA PHARMA CO LTD (JP) 2019-03-14 US disclosed
EP-2751083-B1 QUINOLONE COMPOUND OTSUKA PHARMA CO LTD (JP) 2017-12-27 EP disclosed
US-20170362180-A1 QUINOLONE COMPOUND OTSUKA PHARMA CO LTD (JP) 2017-12-21 US disclosed
US-20170362180-A1 QUINOLONE COMPOUND OTSUKA PHARMA CO LTD (JP) 2017-12-21 US disclosed
US-20160340314-A1 QUINOLONE COMPOUND OTSUKA PHARMA CO LTD (JP) 2016-11-24 US disclosed
US-20160340314-A1 QUINOLONE COMPOUND OTSUKA PHARMA CO LTD (JP) 2016-11-24 US disclosed
US-9440951-B2 Quinolone compound OTSUKA PHARMACEUTICAL CO., LTD (JP) 2016-09-13 US disclosed
US-9440951-B2 Quinolone compound OTSUKA PHARMACEUTICAL CO., LTD (JP) 2016-09-13 US disclosed
US-20150239865-A1 QUINOLONE COMPOUND OTSUKA PHARMA CO LTD (JP) 2015-08-27 US disclosed
US-20150239865-A1 QUINOLONE COMPOUND OTSUKA PHARMA CO LTD (JP) 2015-08-27 US disclosed
US-9067887-B2 Quinolone compound OTSUKA PHARMACEUTICAL CO., LTD (JP) 2015-06-30 US disclosed
US-9067887-B2 Quinolone compound OTSUKA PHARMACEUTICAL CO., LTD (JP) 2015-06-30 US disclosed
US-20150005287-A2 QUINOLONE COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2015-01-01 US disclosed
US-20150005287-A2 QUINOLONE COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2015-01-01 US disclosed
US-20140179675-A1 QUINOLONE COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2014-06-26 US disclosed
US-20140179675-A1 QUINOLONE COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2014-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239865-A1 QUINOLONE COMPOUND HAX1, NQO2, NHERF1 ADRB2 2151/4885STAT3 3477/4885KMT2A 3699/4885
US-20170362180-A1 QUINOLONE COMPOUND HAX1, NQO2, NHERF1 ADRB2 2151/4885STAT3 3477/4885KMT2A 3699/4885
US-20200055823-A1 QUINOLONE COMPOUND HAX1, NQO2, NHERF1 ADRB2 2151/4885STAT3 3477/4885KMT2A 3699/4885
US-20160340314-A1 QUINOLONE COMPOUND HAX1, NQO2, NHERF1 ADRB2 2151/4885STAT3 3477/4885KMT2A 3699/4885
US-20150005287-A2 QUINOLONE COMPOUND HAX1, NQO2, VIP ADRB2 2357/4885STAT3 3218/4885KMT2A 3808/4885
US-20190077762-A1 QUINOLONE COMPOUND HAX1, NQO2, NHERF1 ADRB2 2156/4885STAT3 3536/4885KMT2A 3807/4885
US-20140179675-A1 QUINOLONE COMPOUND HAX1, NQO2, NHERF1 ADRB2 2151/4885STAT3 3477/4885KMT2A 3699/4885
US-20210032207-A1 QUINOLONE COMPOUND HAX1, NQO2, CXCR1 ADRB2 2144/4885STAT3 3421/4885KMT2A 3191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.